References
- GelfandJMShinDBNeimannALWangXMMargolisDJTroxelABThe risk of lymphoma in patients with psoriasisJ Invest Dermatol2006126102194220116741509
- SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin2015621529
- BhattVRVoseJMHematopoietic stem cell transplantation for non-Hodgkin lymphomaHenatol Oncol Clin North Am201428610731095
- BolandMPFosterSJO’NeillLAJDaunorubicin activates NF kappa B and induces kappa B-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cellsJ Biol Chem19972722012952129609148901
- TulpuleARarickMUKolitzJLiposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin’s lymphomaAnn Oncol200112445746211398876
- LothsteinLIsraelMSweatmanTWAnthracycline drug targeting: cytoplasmic versus nuclear – a fork in the roadDrug Resist Updat20014316917711768330
- SzakácsGPatersonJKLudwigJABooth-GentheCGottesmanMMTargeting multidrug resistance in cancerNat Rev Drug Discov20065321923416518375
- GottesmanMMFojoTBatesSEMultidrug resistance in cancer: role of ATP dependent transportersNat Rev Cancer200221485811902585
- LooTWClarkeDMRecent progress in understanding the mechanism of P-glycoprotein-mediated drug effluxJ Member Biol20052063173185
- KlopmanGShiLMRamuAQuantitative structure-activity relationship of multidrug resistance reversal agentsMol Pharmacol19975223233349271356
- FoxEBatesSETariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitorExpert Rev of Anticancer Ther20077444745917428165
- LiXLLuXWXuHEPaclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on “oxidation therapy”Mol Pharm20129222222922171565
- SunMJWangJLuQNovel synthesizing method of pH-dependent doxorubicin-loaded anti-CD22-labelled drug delivery nanosystemDrug Des Devel Ther20159251235133
- SchroederUSommerfeldPUlrichSSabelBANanoparticle technology for delivery of drugs across the blood–brain barrierJ Pharm Sci19988711130513079811481
- XuPPLiJYShiLXSelkeMChenBAWangXMSynergetic effect of functional cadmium–tellurium quantum dots conjugated with gambogic acid for HepG2 cell-labeling and proliferation inhibitionInt J Nanomedicine201383729373624109183
- LiJYWuCYXuPPMultifunctional effects of Cys–CdTe QDs conjugated with gambogic acid for cancer cell tracing and inhibitionRSC Adv201331865186525
- WangLHYangJYYangSNSuppression of NF-KB signaling and P-glycoprotein function by gambogic acid synergistically potentiates adriamycin-induced apoptosis in lung cancerCurr Cancer Drug Targets20141419110324245692
- WangTTWeiJQianXPDingYTYuLXLiuBRGambogic acid, a potent inhibitor of surviving, reverses docetaxel resistance in gastric cancer cellsCancer Lett2008262221422218248784
- YongKTLawWCRoyIAqueous phase synthesis of CdTe quantum dots for biophotonicsJ Biophotonics201141–292020878905
- LiZSXuWWangYTQuantum dots loaded nanogels for low cytotoxicity, pH-sensitive florescence, cell imaging and drug deliveryCarbohydr Polym201512147748525659723
- LiJYShiLXShaoYXThe cellular labeling and pH-sensitive responsive-drug release of celastrol in cancer cells based on Cys-CdTe QDsSci China Chem2014576833841
- KasibhatlaSJessenKAMaliartchoukSA role for transferrin receptor in triggering apoptosis when targeted with gambogic acidProc Natl Acad Sci U S A200510234120951210016103367
- GaponikNTalapinDVRogachALThiol-capping of CdTe nanocrystals: an alternative to organometallic synthetic routesJ Phys Chem B20021062971777185
- YuWWQuLHGuoWZPengXExperimental determination of the extinction coefficient of CdTe, CdSe, and CdS nanocrystalsChem Mater2003151428542860
- WangYZZhangXNXuZLHuangHLLiYPWangJYA pH-sensitive theranostics system based on doxorubicin conjugated with the comb-shaped polymer coating of quantum dotsJ Mater Sci2014492175397546
- ShiJJLiuYWangLA tumoral acidic pH-responsive drug delivery system based on a novel photosensitizer (fullerene) for in vitro and in vivo chemo-photodynamic therapyActa Biomater20141031280129124211343
- QuLZDengDWWangJGuYQDox-conjugated high-quality AgZnInS QDs for reversal for multidrug resistanceJ Innov Opt Health Sci2014711350043
- LiJYWuCHGaoFIn vitro study of drug accumulation in cancer cells via specific association with CdS nanoparticlesBioorg Med Chem Lett200616184808481216844372
- JinJWangFPWeiHLLiuGTReversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrineCancer Chem Pharm2005552179188
- HorwitzSBCohenDRaoSRingleIShenHJYangCPTaxol: mechanisms of action and resistanceJ Natl Cancer Inst1993155561
- GaoZBZhangLNSunYJNanotechnology applied to minimize tumor drug resistanceJ Control Release20121621455522698943
- IyerAKKhaledGFangJMaedaHExploiting the enhanced permeability and retention effect for tumor targetingDrug Discov Today20061117–1881281816935749